Sustained Efficacy and Seroconversion with the Toll-Like Receptor 7 Agonist GS-9620 in the Woodchuck Model of Chronic Hepatitis B

BACKGROUND & AIMS: New therapies for chronic hepatitis B (CHB) are urgently needed since current treatments rarely lead to cure. We evaluated whether the oral small molecule toll-like receptor (TLR7) agonist GS-9620 could induce durable anti-viral efficacy in woodchucks chronically infected with...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Hepatol
Main Authors: Menne, Stephan, Tumas, Daniel B., Liu, Katherine H., Thampi, Linta, AlDeghaither, Dalal, Baldwin, Betty H., Bellezza, Christine A., Cote, Paul J., Zheng, Jim, Halcomb, Randall, Fosdick, Abigail, Fletcher, Simon P., Daffis, Stephane, Li, Li, Yue, Peng, Wolfgang, Grushenka H. I., Tennant, Bud C.
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4439359/
https://ncbi.nlm.nih.gov/pubmed/25559326
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jhep.2014.12.026
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados